We’re excited to welcome Dr. John Byrd to the DNA Nanobots Scientific Advisory Board! Dr. Byrd is a world-renowned expert in blood cancer research with over 600 publications and a track record of guiding breakthrough therapies like rituximab and ibrutinib to FDA approval. Having collaborated with Dr. Byrd for over a decade, we’re thrilled to formalize this partnership. His expertise in translational research, clinical trial design, and regulatory strategy will be key as we advance our delivery platform and therapeutic pipeline. Welcome aboard, Dr. Byrd—we’re looking forward to what’s next! #DNANanobots #ScientificAdvisoryBoard #Innovation https://lnkd.in/g67KimPb
关于我们
With a portfolio of existing IP, DNA Nanobots develops products for targeted therapeutics and functionalized gene delivery. We have a dual approach, building partnerships to provide development expertise in the functionalization of DNA nanotechnology with experience in Gene Delivery, Vaccine Development, Targeted Drug Delivery, Biosensing, Immunotherapy, and Drug Discovery..
- 网站
-
https://dnananobots.com/
DNA Nanobots的外部链接
- 所属行业
- 纳米技术研究
- 规模
- 2-10 人
- 总部
- Powell，Ohio
- 类型
- 私人持股
- 创立
- 2021
- 领域
- DNA Nanotechnology
地点
-
主要
获取路线
1476 Manning Pkwy
US，Ohio，Powell，43065
DNA Nanobots员工
动态
-
DNA Nanobots转发了
Checkout the lineup for Bullpen's JPM Week 2025 Monday Bullpen Cup Pitches. +Featuring Bullpen Club Member Pitchers +5-minute Pitch + 5-minute Q&A +50 Investor Capacity +Bullpen Cup is an invite-only event for Investors #BullpenCup Monday Lineup: 10:15 AM | Emily Fang | InFocus Therapeutics 10:30 AM | Theresa Deisher | AVM Biotechnology 10:45 AM | Jolly Nanda, MBA | Altheia, Inc. 11:00 AM | Dr. Himanshu Misra | EnlitenAI, Inc 11:15 AM | Doug Cohen | IR Medtek 11:30 AM | Tim Mikhelashvili | Amedea Pharma 11:45 AM | Robert Neusner | BMI OrganBank 12:00 PM | Benjamin Fryer | Pluristyx, Inc. 12:15 PM | Oleg Shinkazh | ChromaTan, Inc 12:30 PM | James F. Lynch | DNA Nanobots 12:45 PM | Monika Paule | Caszyme 1:00 PM | Rajib Biswas, PhD | CytoHub Inc. Bullpen is an invite-only Club gathering Life Science Investors and CxOs with a shared goal of helping each other. We prepare for and attend premier industry events together. Our #Mantra: Find Someone to Help. Repeat. Mission: https://lnkd.in/gemP3WGC Membership Inquiries: https://lnkd.in/gfnyBEpK Member Roster: https://lnkd.in/gqJA_nKB Full Schedule: https://lnkd.in/giP5dNkR
-
-
-
-
-
+4
-
-
Thrilled to be on the Hatch Fairhope Podcast to discuss our technology and impact on non-viral gene therapy to save patient lives! Many thanks to Hatch Fairhope Powered By Bessell for the opportunity!
Explore the cutting edge of gene therapy!?In this episode of?The Hatch Podcast, we chat with Christopher Lucas, Ph.D.—Co-Founder and Chief Scientific Officer of DNA Nanobots—about using DNA nanotechnology to revolutionize drug delivery, minimize side effects, and make treatments more accessible. Learn how they went from Ohio State University labs to collaborating with leading pharma companies. Tune in for insights on the future of non-viral gene therapy, the challenges of biotech innovation, and tips for aspiring entrepreneurs. Don’t miss it! https://lnkd.in/d-iYRrys
-
Thanks Ben!
Curating Advanced Therapy Science | Founder @ Convey Bio | I build powerful Linkedin brands for biotech executives that build trust and generate leads
This is one of the most fascinating technologies I've seen in a while. Hands down. Gene therapies typically have two main components: - The therapeutic gene - The outer "case" that protects to the gene and delivers it to the correct location. DNA Nanobots eliminates the need for an outer case entirely. Instead, they use a technique called DNA origami that turns the gene into it's own case. This case can then be coated the markers needed to make it tissue specific. Some of the main benefits of this technique: - No gene size limit - Low immunogenicity - Significantly cheaper to produce Very excited to see where this goes. Many thanks to Christopher Lucas, Ph.D. for the explanation. For the record, the post isn't sponsored - I just think this is really cool :)
-
Thrilled to be joining Chris Danek, Ryan DeBoer, Conner Herman, BCBA, MBA, Greg Parranto, Dr. Mark Coreil, and John A Barrett on an exciting panel next week at CSSi/MTEC @ JPM2025!
Co-Founder & Chief Science Officer | Reshaping the future of healthcare by changing the way we deliver therapeutics through targeted drug delivery technology
Excited to share that I'll be speaking on a panel at CSSi/MTEC at JP Morgan next week, delving into DNA Nanobots's Financing Journey. Can't wait to connect with you all there! #CSSiJPM #MTECJPM #Bessel #DNANanobots #targetednonviralgenetherapy #innovate #impact
-
-
Our team is growing! We’re thrilled to welcome Carolyn Cheney to the DNA Nanobots team as a new Senior Research Scientist! We've convinced Carolyn to come out of her second retirement to bring her unmatched expertise in life science bench work and flow cytometry to help push our research to the next level. We’re so lucky to have someone with her experience and knowledge onboard. Welcome, Carolyn—we can't wait to see the impact you'll make!
-
-
We are thrilled to announce a new chapter at DNA Nanobots! Join us in welcoming James F. Lynch as our new Chief Executive Officer. Jim brings a wealth of executive leadership experience from the biotech industry, poised to steer our innovative efforts to new heights. A heartfelt thank you to Jeff Spitzner, who will transition from CEO to the role of Chief Strategist. Jeff’s visionary leadership has been pivotal in shaping our path, and we look forward to his continued strategic guidance. Together, we are excited about the future and the groundbreaking work ahead in gene therapy and nanotechnology. Welcome aboard, Jim!
-
DNA Nanobots转发了
Co-Founder & Chief Science Officer | Reshaping the future of healthcare by changing the way we deliver therapeutics through targeted drug delivery technology
Thrilled to have been part of a fantastic Kickoff Event for Hatch Fairhope's first Accelerator Cohort last week in Fairhope, Alabama! ?https://lnkd.in/eqMEbxb7 ?? #HatchFairhope #AcceleratorCohort #FairhopeAlabama #InnovateAlabama
-
?? Exciting News from DNA Nanobots! ?? We're thrilled to announce an exclusive commercial licensing of a revolutionary gene editing technology from UC Berkeley. This cutting-edge tech allows for 'folding' of genes into their own delivery devices, enhancing non-viral gene delivery with efficiency and precision. ?? Discover more about how we're leveraging this technology to overcome the limitations of traditional viral gene delivery methods and push the boundaries of genetic medicine. Our goal is to provide innovative solutions for rare diseases and cancers, emphasizing safety, efficacy, and accessibility. Read more about our recent deal here: https://lnkd.in/gdJ-p5kT #DNANanobots #GeneTherapy #Biotechnology #Innovation #CRISPR #UCBerkeley
-
Come visit our CTO at AACR if you’re still around!
#AACR24 Poster number 2! Come visit with me today (section 27, poster 5) and chat about “Exploring the potential of targeted DNA Nanobot delivery systems for gene delivery” DNA Nanobots